Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review

被引：23
作者：
Da Cunha, Teresa [1 ]
Vaziri, Haleh [1 ]
Wu, George Y. [1 ]
机构：
[1] Univ Connecticut, Ctr Hlth, Dept Med, Div Gastroenterol Hepatol, Farmington, CT USA
来源：
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY | 2022年 / 10卷 / 03期
关键词：
Primary sclerosing cholangitis; Cholangitis; Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; GENOME-WIDE ASSOCIATION; BILIARY EPITHELIAL-CELLS; CEREVISIAE ANTIBODIES ASCA; ULCERATIVE-COLITIS; T-CELLS; CLINICAL-SIGNIFICANCE; INCREASED PREVALENCE; CYSTIC-FIBROSIS; CROHNS-DISEASE; HLA ANTIGENS;
D O I：
10.14218/JCTH.2021.00344
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Primary sclerosing cholangitis is a disease affecting around 0.006-0.016% of the population. Of these, around 75% have concomitant inflammatory bowel disease (IBD) according to the most recent epidemiological studies. Several theories have been proposed regarding the pathogenesis of primary sclerosing cholangitis (PSC). These include changes in the function of cholangiocytes, effects of the gut microbiome, association with specific human leukocyte antigen haplotypes and dysregulation of the immune system. However, these do not explain the observed association with IBD. Moreover, there are considerable differences in the frequency and outcomes between patients with PSC and ulcerative colitis compared with PSC and Crohn's disease. The aim of this review is to appraise the most recent studies that have contributed to the epidemiology, advances in the pathophysiology, and characterization of important clinical aspects of the association of PSC and IBD.
引用
收藏
页码：531 / 542
页数：12
相关论文
共 76 条
[61]   HLA ANTIGENS AND IMMUNOREGULATORY T-CELLS IN ULCERATIVE-COLITIS ASSOCIATED WITH HEPATOBILIARY DISEASE [J].
SCHRUMPF, E ;
FAUSA, O ;
FORRE, O ;
DOBLOUG, JH ;
RITLAND, S ;
THORSBY, E .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1982, 17 (02) :187-191
[62]   The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation [J].
Schrumpf, Elisabeth ;
Kummen, Martin ;
Valestrand, Laura ;
Greiner, Thomas U. ;
Holm, Kristian ;
Arulampalam, Velmurugesan ;
Reims, Henrik M. ;
Baines, John ;
Backhed, Fredrik ;
Karlsen, Tom H. ;
Blumberg, Richard S. ;
Hov, Johannes R. ;
Melum, Espen .
JOURNAL OF HEPATOLOGY, 2017, 66 (02) :382-389
[63]   CLINICAL-SIGNIFICANCE OF ANTIBODIES AGAINST NEUTROPHILS IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS [J].
SEIBOLD, F ;
WEBER, P ;
KLEIN, R ;
BERG, PA ;
WIEDMANN, KH .
GUT, 1992, 33 (05) :657-662
[64]   Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis [J].
Sheth, S ;
Shea, JC ;
Bishop, MD ;
Chopra, S ;
Regan, MM ;
Malmberg, E ;
Walker, C ;
Ricci, R ;
Tsui, LC ;
Durie, PR ;
Zielenski, J ;
Freedman, SD .
HUMAN GENETICS, 2003, 113 (03) :286-292
[65]   Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis [J].
Srivastava, Brijesh ;
Mells, George F. ;
Cordell, Heather J. ;
Muriithi, Agnes ;
Brown, Matthew ;
Ellinghaus, Eva ;
Franke, Andre ;
Karlsen, Tom H. ;
Sandford, Richard N. ;
Alexander, Graeme J. ;
Chapman, Roger W. ;
Rushbrook, Simon M. ;
Melum, Espen .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (07) :820-826
[66]   PR3-ANCA: A Promising Biomarker in Primary Sclerosing Cholangitis (PSC) [J].
Stinton, Laura M. ;
Bentow, Chelsea ;
Mahler, Michael ;
Norman, Gary L. ;
Eksteen, Bertus ;
Mason, Andrew L. ;
Kaplan, Gilaad G. ;
Lindkvist, Bjorn ;
Hirschfield, Gideon M. ;
Milkiewicz, Piotr ;
Cheung, Angela ;
Janssen, Harry L. A. ;
Fritzler, Marvin J. .
PLOS ONE, 2014, 9 (11)
[67]   Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis [J].
Tabibian, James H. ;
O'Hara, Steven P. ;
Trussoni, Christy E. ;
Tietz, Pamela S. ;
Splinter, Patrick L. ;
Mounajjed, Taofic ;
Hagey, Lee R. ;
LaRusso, Nicholas F. .
HEPATOLOGY, 2016, 63 (01) :185-196
[68]   Cholangiocyte Senescence by Way of N-Ras Activation Is a Characteristic of Primary Sclerosing Cholangitis [J].
Tabibian, James H. ;
O'Hara, Steven P. ;
Splinter, Patrick L. ;
Trussoni, Christy E. ;
LaRusso, Nicholas F. .
HEPATOLOGY, 2014, 59 (06) :2263-2275
[69]   The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis [J].
Trauner, Michael ;
Gulamhusein, Aliya ;
Hameed, Bilal ;
Caldwell, Stephen ;
Shiffman, Mitchell L. ;
Landis, Charles ;
Eksteen, Bertus ;
Agarwal, Kosh ;
Muir, Andrew ;
Rushbrook, Simon ;
Lu, Xiaomin ;
Xu, Jun ;
Chuang, Jen-Chieh ;
Billin, Andrew N. ;
Li, Georgia ;
Chung, Chuhan ;
Subramanian, G. Mani ;
Myers, Robert P. ;
Bowlus, Christopher L. ;
Kowdley, Kris V. .
HEPATOLOGY, 2019, 70 (03) :788-801
[70]   The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity [J].
Vavassori, Piero ;
Mencarelli, Andrea ;
Renga, Barbara ;
Distrutti, Eleonora ;
Fiorucci, Stefano .
JOURNAL OF IMMUNOLOGY, 2009, 183 (10) :6251-6261
12345678